Embryo Selection and Morphokinetics: Can Time-Lapse Imaging Help Identify the Most Viable Embryo?

In assisted reproductive technology (ART), selecting the embryo with the highest potential to result in a live birth remains one of the most important challenges in in vitro fertilization (IVF). Although conventional morphological assessment is the foundation of embryo evaluation, it provides only a limited view of a complex, dynamic developmental process. Time-lapse imaging (TLI) offers an additional perspective by allowing embryologists to observe embryo development continuously and assess not only what an embryo looks like, but also how it develops over time.

This approach has introduced morphokinetics into routine embryology discussions and raised an important question: Can the timing and sequence of early embryonic events help identify the most viable embryo?

The answer requires a distinction between biological promise and demonstrated clinical benefit. Time-lapse imaging provides valuable developmental information, but current evidence does not establish that its use for embryo selection consistently increases live-birth rates compared with conventional methods. Understanding its capabilities, limitations, and appropriate clinical application is essential for IVF laboratories seeking to improve the quality and consistency of embryo assessment.

 

What Is Time-Lapse Imaging in IVF?

Time-lapse imaging is a technology that captures images of developing embryos at predefined intervals while they remain inside a controlled culture environment. These images are compiled into a sequence or video, allowing embryologists to review developmental events retrospectively and observe changes that might be missed during conventional, periodic microscopic assessment.

In conventional embryo culture, embryologists typically remove embryos from the incubator at scheduled intervals to assess their morphology. Although this method is well established, each assessment provides a snapshot of development rather than a continuous record.

Time-lapse systems combine embryo culture with integrated imaging, allowing development to be monitored without repeatedly removing embryos from the incubator for observation. Depending on the system, images may be acquired every several minutes and at multiple focal planes.

The main potential advantages are:

• Continuous developmental monitoring: Embryologists can review the timing and sequence of key developmental events.
• Reduced handling for observation: Embryos can be assessed without routine removal from the time-lapse incubator for each observation.
• Retrospective review: Developmental events can be examined again when clarification or discussion is needed.
• More detailed assessment: Transient events, abnormal cleavage patterns, and other developmental features may become easier to identify.
• Improved documentation: Digital records can support staff training, quality assurance, and laboratory research.

Importantly, the use of time-lapse imaging does not automatically mean that embryos are selected using morphokinetic algorithms. A laboratory may use the technology primarily for uninterrupted culture and conventional morphological assessment, or it may incorporate developmental timing into its embryo-ranking process. These are distinct applications and should be evaluated separately.

 

Understanding Morphokinetics: What Does Embryo Development Over Time Reveal?

Morphokinetics refers to the timing and dynamics of morphological changes during embryo development. In IVF, this typically involves recording when specific developmental events occur and how the embryo progresses from fertilization through cleavage and, when extended culture is used, blastocyst formation.

Conventional morphological assessment evaluates characteristics such as cell number, blastomere symmetry, fragmentation, multinucleation, and blastocyst structure. Morphokinetic assessment adds a temporal dimension to these observations.

Several developmental parameters are commonly evaluated.

1. Time to the first cleavage divisions

After normal fertilization, the zygote begins dividing into blastomeres. Time-lapse imaging can record the timing of the first and subsequent mitotic divisions.

Parameters commonly used in research and some selection systems include:

• t2: Time from the defined starting point, usually insemination or intracytoplasmic sperm injection (ICSI), to the two-cell stage.
• t3: Time to the three-cell stage.
• t4: Time to the four-cell stage.
• t5: Time to the five-cell stage.

These measurements help characterize the pace of early embryo development. Certain developmental patterns have been associated with implantation potential or subsequent embryo development in specific study populations.

However, faster development is not necessarily better in every circumstance. The interpretation depends on the sequence of events, the presence of abnormalities, the culture protocol, and the characteristics of the patient population. A single time measurement should not be treated as an independent measure of embryo viability.

2. Cell-cycle duration and synchrony

Additional parameters describe the intervals between successive divisions.

For example, cc2 commonly refers to the interval between the two-cell and three-cell stages, while s2 describes the interval between the appearance of the second and third blastomeres in a cleavage sequence. Exact operational definitions should follow the annotation protocol used by the laboratory or software.

These parameters can provide information about the coordination of early cell divisions. Deviations from expected patterns may be associated with developmental abnormalities, although their predictive value varies across studies and systems.

The practical objective is not to identify one universally optimal cell-cycle duration. It is to determine whether developmental timing provides useful information when interpreted alongside morphology and the broader clinical context.

3. Abnormal cleavage patterns

One of the important contributions of time-lapse imaging is the ability to detect developmental events that may be difficult to identify through occasional observations.

For example, direct cleavage can occur when a blastomere divides directly into three or more daughter cells rather than following the expected bipolar division pattern. Other abnormal events may include reverse cleavage, irregular division sequences, or transient cellular abnormalities.

Some of these patterns have been associated with reduced developmental competence or poorer reproductive outcomes. Their identification can therefore contribute to a more complete assessment of an embryo.

Nevertheless, the presence of an abnormal event should be interpreted in context. The significance of a particular observation depends on the event itself, the developmental stage, the quality of the recorded images, and the embryo's subsequent development.

4. Blastocyst formation and expansion

When embryos are cultured to the blastocyst stage, time-lapse imaging can document the timing of blastulation, cavity expansion, and other developmental changes.

Blastocyst assessment also includes established morphological criteria, such as the appearance of the inner cell mass and trophectoderm. These characteristics remain important components of embryo grading.

Developmental timing may provide complementary information, but reaching the blastocyst stage earlier does not, by itself, establish that an embryo is chromosomally normal or will result in a live birth.

 

How Can Morphokinetics Support Embryo Selection?

The principal rationale for incorporating morphokinetics into embryo selection is that embryos with similar appearances at a particular observation point may have followed different developmental trajectories.

Two embryos may both appear morphologically acceptable, yet one may have developed through a relatively regular sequence of cell divisions while the other may have experienced abnormal cleavage or irregular developmental progression. Time-lapse imaging allows embryologists to consider these differences.

In practice, morphokinetic information may support embryo selection in three main ways.

First, it adds developmental context to morphological grading. Instead of relying exclusively on an embryo's appearance at a particular time, embryologists can consider how it reached that stage.

Second, it can help identify potentially unfavorable developmental events. Recognizing abnormal cleavage patterns or other atypical events may inform the ranking of embryos within a cohort.

Third, it supports more systematic documentation and review. Recorded developmental sequences can facilitate multidisciplinary discussions, staff training, and the investigation of unexpected laboratory outcomes.

These benefits should not be confused with proof of improved treatment success. A parameter can be associated with implantation or developmental outcomes without providing enough additional predictive information to improve the selection of embryos in routine clinical practice.

This distinction is central to interpreting the scientific evidence.

 

What Does the Clinical Evidence Say?

Research on time-lapse imaging has evolved from observational studies of developmental timing to randomized controlled trials evaluating patient outcomes. The overall picture is more nuanced than early enthusiasm for morphokinetic selection might suggest.

Observational studies: Identifying associations

Early research identified associations between particular morphokinetic patterns and subsequent embryo development or implantation. These studies helped establish the scientific basis for investigating developmental timing as an additional embryo-selection tool.

However, associations do not necessarily establish predictive accuracy in different clinical settings. Studies may differ in patient characteristics, culture conditions, embryo assessment protocols, software algorithms, and definitions of successful outcomes.

A parameter that performs well in one laboratory may not have the same predictive value elsewhere. This is one reason why morphokinetic selection algorithms require careful validation before being adopted as routine decision-making tools.

Systematic review and meta-analysis: Evidence remains limited

A systematic review and meta-analysis published by Jiang and colleagues in 2023 evaluated randomized controlled trials comparing time-lapse monitoring with conventional embryo assessment.

The authors found that time-lapse incubation with morphological assessment did not consistently improve live-birth rates, ongoing pregnancy rates, or clinical pregnancy rates compared with conventional incubation. They also found that selecting embryos using morphokinetic information did not demonstrate improved reproductive outcomes over conventional morphological selection.

The findings highlighted an important limitation: additional information about embryo development does not automatically translate into better clinical outcomes.

Reference: Jiang et al., Journal of Obstetrics and Gynaecology Research, 2023.

The TILT trial: A major randomized controlled study

A particularly important contribution to the evidence base is the TILT trial, published in The Lancet in July 2024.

This multicentre, three-arm, double-blind randomized controlled trial included 1,575 participants undergoing IVF or ICSI at seven fertility centres in the United Kingdom and Hong Kong.

The trial compared three approaches:

1. Time-lapse imaging with undisturbed culture and embryo selection based on morphology and morphokinetic parameters.
2. Undisturbed culture in time-lapse incubators, with embryo selection based on conventional morphology alone.
3. Standard embryo culture and conventional morphological assessment without time-lapse imaging.

The primary outcome was live birth following the first embryo transfer.

The reported live-birth rates were:

• 33.7% in the time-lapse imaging group.
• 36.6% in the undisturbed culture group.
• 33.0% in the standard-care group.

The differences were not statistically significant. The investigators concluded that time-lapse imaging systems used for embryo incubation and selection did not significantly increase the odds of live birth compared with standard care.

The study is especially informative because its three-group design helped distinguish the potential contribution of undisturbed culture from that of morphokinetic embryo selection.

These findings do not mean that time-lapse imaging has no value. They mean that its routine use should not be presented as a proven way to increase the probability of live birth.

Reference: Bhide et al., The Lancet, 2024.

 

Can Time-Lapse Imaging Identify the Most Viable Embryo?

The answer depends on what is meant by viability.

Embryo viability is not a single characteristic that can be measured directly through developmental timing. In clinical practice, embryo assessment attempts to estimate the likelihood of successful implantation and ultimately live birth using available morphological, developmental, and, when indicated, genetic information.

Time-lapse imaging can provide additional evidence about developmental competence. It may help embryologists distinguish between embryos with different developmental histories, identify potentially unfavorable events, and improve the documentation of embryo development.

However, time-lapse imaging cannot reliably determine, on its own, which embryo will produce a live birth.

Several factors explain this limitation.

First, embryo morphology and morphokinetics reflect aspects of development but do not provide a complete assessment of chromosomal status. An embryo with an apparently favorable developmental pattern may still carry chromosomal abnormalities.

Second, implantation and live birth depend on multiple factors beyond embryo appearance and developmental timing, including uterine factors, patient characteristics, and other biological variables.

Third, predictive algorithms are not necessarily transferable between laboratories. Differences in equipment, culture systems, annotation practices, and patient populations can influence the performance of morphokinetic models.

Finally, the predictive value of a selection method is different from its clinical utility. Even if a model can rank embryos according to their estimated potential, it must still be shown that using that ranking improves outcomes compared with established practice.

Time-lapse imaging should therefore be considered an additional assessment tool rather than a definitive test of embryo viability.

 

Time-Lapse Imaging and PGT-A: Different Questions, Different Tools

Preimplantation genetic testing for aneuploidy (PGT-A) and morphokinetic assessment are sometimes discussed together, but they serve different purposes.

Morphokinetic assessment evaluates the timing and pattern of embryo development. PGT-A examines genetic material from a biopsy of trophectoderm cells to assess chromosome copy-number abnormalities, subject to the limitations of the testing method and sample.

Some studies have investigated whether morphokinetic parameters correlate with embryo ploidy. Although associations have been reported, developmental timing is not sufficiently reliable to determine whether an embryo is euploid or aneuploid.

Accordingly, time-lapse imaging cannot replace genetic testing when genetic testing is clinically indicated. Nor should a favorable morphokinetic profile be interpreted as evidence that an embryo is genetically normal.

The decision to use PGT-A should be made according to the clinical context, relevant evidence, and the recommendations of the treating fertility team.

 

Practical Recommendations for IVF Laboratories

For laboratories considering the introduction or optimization of time-lapse technology, the key question is not simply whether the system captures more images. It is whether the technology serves a clearly defined clinical or operational purpose and is used consistently.

The following practices can support responsible implementation.

1. Define the intended clinical purpose

Before adopting a time-lapse system, determine whether the primary objective is to support undisturbed culture, improve developmental documentation, facilitate staff training, or incorporate morphokinetic information into embryo ranking.

Different objectives require different evaluation criteria. A system used primarily for culture and documentation should not be judged solely by the predictive performance of an embryo-selection algorithm.

2. Standardize developmental annotation

Embryologists should use consistent definitions for the starting point of timing measurements and for each developmental event. Annotation protocols should clearly describe how cleavage events, abnormal divisions, and blastocyst development are recorded.

Consistent annotation reduces avoidable variability and improves the interpretability of developmental records.

3. Validate algorithms in the local laboratory

Published morphokinetic thresholds should not automatically be adopted as universal standards.

If software is used to rank or deselect embryos, its performance should be assessed against the laboratory's own patient population, culture conditions, and clinical outcomes. Validation should consider whether the model adds useful information beyond conventional morphological assessment.

The laboratory should also monitor whether performance remains consistent over time and across embryologists.

4. Integrate morphokinetics with established assessment methods

Morphokinetic parameters should complement, rather than automatically replace, conventional morphological grading and clinical judgment.

Embryo selection should account for the full developmental record, recognized morphological criteria, relevant patient factors, and the laboratory's validated procedures. An algorithmic score should not be treated as an independent guarantee of implantation or live birth.

5. Establish quality assurance and staff training

A time-lapse system requires appropriate installation, training, maintenance, and quality control. Laboratories should define staff responsibilities, establish standard operating procedures, and ensure that embryologists understand both the capabilities and limitations of the technology.

Technical reliability, image quality, consistent data recording, and appropriate interpretation are all necessary for meaningful use.

6. Evaluate clinical outcomes, not just laboratory metrics

A laboratory may observe improvements in workflow, documentation, or the identification of developmental events without demonstrating improved reproductive outcomes.

Where feasible, laboratories should evaluate outcomes such as live birth, cumulative live birth, embryo utilization, and other relevant clinical endpoints. Comparisons should account for differences in patient characteristics and treatment protocols.

The selected outcome measures should reflect the intended purpose of the technology and be interpreted using appropriate statistical methods.

7. Communicate the evidence accurately

Patients and referring clinicians should receive balanced information about what time-lapse imaging can and cannot establish.

The availability of a time-lapse system should not be equated with a guaranteed increase in IVF success. Where additional costs are involved, clinics should explain the intended benefit, the limitations of the available evidence, and the distinction between improved observation and improved clinical outcomes.

These principles are consistent with the European Society of Human Reproduction and Embryology (ESHRE) good practice recommendations for time-lapse technology.

 

The Future of Time-Lapse Imaging: Standardization, Data, and Artificial Intelligence

Time-lapse imaging creates extensive developmental datasets that can support research into embryo assessment. When combined with appropriately designed analytical methods, these datasets may help researchers investigate complex relationships between developmental patterns and reproductive outcomes.

Artificial intelligence (AI) is one area of active investigation. Machine-learning models can analyze image sequences and may identify patterns that are difficult to quantify consistently through manual assessment.

However, the clinical usefulness of AI-assisted embryo selection depends on more than its ability to analyze images or predict outcomes in a development dataset. Models need robust external validation, representative patient populations, transparent performance assessment, and evidence that their use improves clinically meaningful outcomes.

Researchers must also consider the risk of overfitting, differences between laboratories, potential algorithmic bias, and whether an apparent improvement in prediction actually changes clinical decisions.

Future progress will therefore depend not only on more sophisticated imaging and algorithms, but also on standardized data collection, reproducible methods, and prospective clinical evaluation.

 

Conclusion: A Valuable Tool, but Not a Definitive Predictor

Time-lapse imaging has expanded the ability of embryologists to observe and document embryo development. By recording cleavage events, developmental timing, and abnormal patterns, it provides information that conventional periodic assessment may not capture.

Morphokinetics offers a biologically plausible way to complement morphological grading and improve the characterization of developing embryos. Nevertheless, the available evidence, including the 2024 TILT randomized controlled trial, does not demonstrate that routine use of time-lapse imaging for embryo selection consistently improves live-birth rates.

For IVF laboratories, the most defensible approach is to use time-lapse technology according to a clearly defined purpose, maintain standardized assessment procedures, validate selection algorithms locally, and monitor meaningful clinical outcomes.

Ultimately, the objective of embryo selection is not to identify the embryo with the most favorable-looking developmental timeline. It is to make the best evidence-based decision for each patient while recognizing the limitations of every available assessment method.

At rada, we recognize the importance of reliable medical technologies in assisted reproduction and women's health. Continued attention to scientific evidence, laboratory quality, and the practical needs of healthcare professionals is essential to supporting informed decisions and high-quality patient care.

 

 

References

1. Apter S, Ebner T, Freour T, et al.; ESHRE Working Group on Time-lapse Technology. Good practice recommendations for the use of time-lapse technology. Human Reproduction Open. 2020;2020(2).
2. Bhide P, Chan DYL, Lanz D, et al. Clinical effectiveness and safety of time-lapse imaging systems for embryo incubation and selection in in-vitro fertilisation treatment (TILT): a multicentre, three-parallel-group, double-blind, randomised controlled trial. The Lancet. 2024;404(10449):256–265.
3. Jiang Y, Wang L, Wang S, et al. The effect of embryo selection using time-lapse monitoring on IVF/ICSI outcomes: A systematic review and meta-analysis. Journal of Obstetrics and Gynaecology Research. 2023;49(12):2792–2803.
4. Armstrong S, Bhide P, Jordan V, Pacey A, Marjoribanks J, Farquhar C. Time-lapse systems for embryo incubation and assessment in assisted reproduction. Cochrane Database of Systematic Reviews. 2019;5.
5. Berman A, Anteby R, Efros O, Klang E, Soffer S. Deep learning for embryo evaluation using time-lapse: a systematic review of diagnostic test accuracy. American Journal of Obstetrics and Gynecology. 2023;229(5):490–501.
6. Zaninovic N, Rosenwaks Z. Artificial intelligence in human in vitro fertilization and embryology. Fertility and Sterility. 2020;114(5):914–920.